22nd Century Group Announces Completion of Cannabis Business Sale
According to a report by Marketscreener on December 28, the American biotechnology company, 22nd Century Group, Inc., has announced the completion of the sale transaction for its cannabis business. This transaction will significantly reduce the company's operating expenses in the future and is a crucial step towards achieving positive cash flow.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
